ARGNF:OTCMKTS
argenx SE
၇၉၀.၁၅ US$
၀.၀၀%
(၀.၀၀) 1D
အောက် ၁၃, GMT-၄ ၁၀:၃၉:၅၈ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARGNF...
Mkt. cap
ဋေ ၅.၁၅ ထ
Avg. vol.
၁၄.၀၀
Volume
၀.၀၀
52-wk high
၁,၀၂၀.၀၀ US$
52-wk low
၇၀၈.၇၂ US$
Beta
၀.၄၆
Shares outstanding
၆.၂၉ ကုဋေ
No. of employees
၂ ထောင်
Mkt. cap
ဋေ ၅.၁၅ ထ
Avg. vol.
၁၄.၀၀
Volume
၀.၀၀
52-wk high
၁,၀၂၀.၀၀ US$
52-wk low
၇၀၈.၇၂ US$
Beta
၀.၄၆
Shares outstanding
၆.၂၉ ကုဋေ
No. of employees
၂ ထောင်
News stories
From web sources and news partners
ad-hoc-news.de
·
ပြီးခဲ့သည့် ၁၁ နာရီ
argenx reports trial results: what it means for argenx stock
TipRanks
·
ပြီးခဲ့သည့် ၂၂ နာရီ
Argenx Stock Stumbles As Trial Failure Haunts Rally
Yahoo Finance
·
ပြီးခဲ့သည့် ၁ ရက်
Zacks Investment Ideas feature highlights: Cummins, Argenx and PACCAR
Simply Wall Street
·
ပြီးခဲ့သည့် ၃ ရက်
Halozyme Stock Has The Bull Case Changed After Argenx Deal Expansion?
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE